MHRA's Ian Holloway on Revision Annex 16 of the GMP Guide and the Cold Chain




Ian Holloway, Manager of the Defective Medicines Report Centre at the Medicines and Healthcare products Regulatory Agency (MHRA), joins Andrea Charles from Cold Chain IQ, to discuss how the role of the Qualified Person (QP) is changing and its impact on the cold chain. Holloway also shares his insights on Revision Annex 16 of the GMP Guide and the possible impact on cold chain operations. Finally Holloway talks about the effectiveness of Quality Systems and whether they are being over promoted.

This video was filmed at the 11th Annual Cool Chain Logistic Europe.

Have Your Say
Rate this feature and give us your feedback in the comments section below
Ian Holloway, Manager of the Defective Medicines Report Centre at the Medicines and Healthcare products Regulatory Agency (MHRA), joins Andrea Charles from Cold Chain IQ, to discuss how the role of the Qualified Person (QP) is changing and its impact on the cold chain. Holloway also shares his insights on Revision Annex 16 of the GMP Guide and the possible impact on cold chain operations. Finally Holloway talks about the effectiveness of Quality Systems and whether they are being over promoted.
To continue reading this story

Learn More   Existing Users